The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product
about
IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activationActivation of RelA homodimers by tumour necrosis factor alpha: a possible transcriptional activator in human vascular endothelial cellsI kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA bindingPurification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 geneCoupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activationCloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alphaA novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerizationDimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleusThe G9a gene in the human major histocompatibility complex encodes a novel protein containing ankyrin-like repeatsRegulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalphaA novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase geneNF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunitStructure and expression of major histocompatibility complex-binding protein 2, a 275-kDa zinc finger protein that binds to an enhancer of major histocompatibility complex class I genesThe p65 subunit is responsible for the strong transcription activating potential of NF-kappa BThe NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa BReactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent mannerPurification of early-B-cell factor and characterization of its DNA-binding specificityBoth N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motifEvolutionary variation of the CCAAT-binding transcription factor NF-YPurification, reconstitution, and I kappa B association of the c-Rel-p65 (RelA) complex, a strong activator of transcriptionCyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokinesNF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeThe RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoproteinA novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B siteSpecific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcriptionInteraction of the v-Rel oncoprotein with cellular transcription factor Sp1Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expressionRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsRegulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteinsRegulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene productstra-2 encodes a membrane protein and may mediate cell communication in the Caenorhabditis elegans sex determination pathwayCytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa BPhysical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cellsControl of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alphaT cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cellsTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication
P2860
Q24290171-7CBADD48-6842-4415-8534-28B9AA717747Q24293705-C71A4C24-5FA5-402B-B62F-5C9677A1D926Q24301448-0C5EF1C2-4AD7-41CC-887D-B7FC31FC2F6AQ24307786-6B2EFC1D-7955-4E3F-9153-963F1B472C60Q24312701-E04029B1-729D-46B7-9077-156341AA7C37Q24316905-9130C728-88CB-4770-9588-4E9712691F1FQ24318577-F7EBAE30-B192-42DD-9534-D947CFB195AFQ24320246-B11EF5AE-6E25-4515-AAFA-B6C242246435Q24321796-95F2BAFC-ABE6-4E1C-B51F-F0A256D2005CQ24337591-C3968E20-BCF1-4C8F-96C7-FAD8E0838675Q24527670-B8E37DAC-A50B-418D-93E3-4C53B60AFB97Q24532251-73E09C63-3597-47B9-8345-925F265649E0Q24548385-245BE65F-8C4B-4344-94A9-CDF7C2F81932Q24555708-E63D0E23-D9A7-4C75-A240-37DB5BDC5175Q24561421-1092907D-7EC0-4527-8FE0-259399120F2FQ24563836-974FB253-9628-4E28-93EC-881B151CA56CQ24564667-153A00B3-E17E-4A89-A474-78A6EA8C32B4Q24564833-BAA719E7-78C1-4E24-9804-D28A07F942E4Q24564855-FAC66D1B-90DD-46C9-A3CD-30198486F34BQ24604635-9A3CBCDE-D769-4D18-87CF-6DB574FFC364Q24604697-BDAA2F25-FCFF-40D4-870F-5E3925187FF2Q24606830-984CE2F9-4C07-4EA4-9763-3296F8A46399Q24608611-52BB5902-516A-4465-9C46-873382A49A49Q24613327-0309A7A8-0D52-4C9A-93A8-DD6E88FD072AQ24629510-872FF634-0465-44EF-B42F-18FD6D34B78EQ24629772-2B049C8A-3005-48DE-9DCD-147E9B8C2BA3Q24630135-CCD00EF6-57FC-4626-9E4E-9879C91432FDQ24630534-B894B802-D6D9-416E-83F1-F2625B780D5CQ24645001-89F47E9A-D99C-461D-B739-323D09D6427CQ24645607-6877B2B3-7AD1-4190-8259-59DB0A937C50Q24647749-95923A31-8E7C-473D-B65F-FD0AF3A8463EQ24651506-64883DD2-5349-459A-90FD-97BCACFEA26DQ24652745-174F96F5-B0D7-4E8E-BB09-55A95AF68848Q24655654-D2501721-0956-481E-ACC7-168A5CE9645FQ24658251-DFC68E8D-2C2B-49E6-9828-5C2F166E52B1Q24672676-6442629F-4D0F-4D06-90D8-B0E678CA56E7Q24675272-41C66FAC-698A-4F68-BE81-DB344688AF0AQ24676497-3CA026E0-5AA2-4DF0-A31A-75AE8386452DQ24678251-09DAC52A-02A3-4587-80A3-A27BB6E8EF3BQ24681560-9D4777FA-E723-437A-8815-83692778C723
P2860
The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product
description
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1990
@ast
im September 1990 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 7 September 1990)
@en
wetenschappelijk artikel (gepubliceerd op 1990/09/07)
@nl
наукова стаття, опублікована у вересні 1990
@uk
مقالة علمية (نشرت في 7-9-1990)
@ar
name
The DNA binding subunit of NF- ...... us to the rel oncogene product
@ast
The DNA binding subunit of NF- ...... us to the rel oncogene product
@en
type
label
The DNA binding subunit of NF- ...... us to the rel oncogene product
@ast
The DNA binding subunit of NF- ...... us to the rel oncogene product
@en
prefLabel
The DNA binding subunit of NF- ...... us to the rel oncogene product
@ast
The DNA binding subunit of NF- ...... us to the rel oncogene product
@en
P2093
P3181
P1433
P1476
The DNA binding subunit of NF- ...... us to the rel oncogene product
@en
P2093
Baeuerle PA
Kourilsky P
Lottspeich F
Vandekerckhove J
P304
P3181
P356
10.1016/0092-8674(90)90275-J
P407
P577
1990-09-07T00:00:00Z